Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlota Claussen"'
Autor:
Carlota Claussen, Lars Hanker
Publikováno v:
Der Gynäkologe. 55:176-183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ed5933e4d0dce52159577b82f8129dc
https://doi.org/10.1007/s00129-022-04904-x
https://doi.org/10.1007/s00129-022-04904-x
Autor:
Achim Rody, Carlota Claussen
Publikováno v:
Der Gynäkologe. 54:309-319
In den letzten Jahren hat sich die endokrine Therapie des hormonrezeptorpositiven, lokal fortgeschrittenen/metastasierten Mammakarzinoms erfolgreich weiterentwickelt. Neue Substanzen wurden entwickelt, um endokrine Resistenzen zu uberwinden, altbekan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::395c08100a90c36484f5e697f5cb931f
https://doi.org/10.1007/s00129-021-04792-7
https://doi.org/10.1007/s00129-021-04792-7
Publikováno v:
Geburtshilfe und Frauenheilkunde
Epithelial ovarian cancer is the most common cause of death from gynecological tumors. Most patients with advanced ovarian cancer develop recurrence after concluding first-line therapy, making further lines of therapy necessary. The choice of therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20b9b5dd26e978ad5f94ea8f06a3cd4d
https://doi.org/10.1055/a-1128-0280
https://doi.org/10.1055/a-1128-0280
Publikováno v:
Kompass Onkologie. 8:140-142
The PIKTAM study evaluated the efficacy and safety of the PI3K inhibitor buparlisib in combination with tamoxifen in hormone receptor-positive (HR+), HER2-negative advanced breast cancer patients after failure of prior endocrine therapy. In this open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::340069e4ca16844d466c7da6b7d9bbf2
https://doi.org/10.1159/000518823
https://doi.org/10.1159/000518823
Autor:
Barbara Schmalfeldt, Sven Mahner, Florian Länger, Carsten Bokemeyer, Susanne Lezius, John L. Francis, Yohei Hisada, Alma Verena Rausch, Ali Amirkhosravi, Monica Davila, Carlota Claussen, Nigel Mackman
Publikováno v:
Thrombosis research. 146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2dc138a4224ba36eb72fc35c4fbf134
https://pubmed.ncbi.nlm.nih.gov/26967531
https://pubmed.ncbi.nlm.nih.gov/26967531
Autor:
Carlota Claussen, Sven Mahner, John L. Francis, Yohei Hisada, Susanne Lezius, Barbara Schmalfeldt, Ali Amirkhosravi, Nigel Mackman, Florian Länger, Alma Verena Rausch, Monica Davila, Carsten Bokemeyer
Publikováno v:
Thrombosis research. 141
Background: Tissue factor (TF) is involved in tumor growth and metastasis and contributes to venous thromboembolism( VTE) in cancer, including gynecological malignancies. The diagnostic value of microvesicle-associated TF procoagulant activity (MV TF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0386dfd975fe07b6dd3d8751953bef
https://pubmed.ncbi.nlm.nih.gov/27640329
https://pubmed.ncbi.nlm.nih.gov/27640329